Displaying drugs 4651 - 4675 of 5559 in total
COTI-2
Investigational
NPT520-34
Investigational
Fipaxalparant
Investigational
Anti-CD7 CAR T-cell therapy
Investigational
Tavokinogene telseplasmid
Tavokinogene telseplasmid consists of a DNA Plasmid Vector Encoding IL-12.
Investigational
LP-184
Investigational
N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda~4~-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide
N-[(2S,4S,6R)-2-(dihydroxymethyl)-4-hydroxy-3,3-dimethyl-7-oxo-4lambda~4~-thia-1-azabicyclo[3.2.0]hept-6-yl]-2-phenylacetamide is a solid. This compound belongs to the penicillins. These are organic compounds containing the penicillin core structure, which is structurally characterized by a penam ring bearing two methyl groups at position 2, and an amide group at position 6 [starting from the sulfur atom at position 1]. This...
Experimental
Bolandiol
Experimental
Illicit
Glutathionylspermidine
Experimental
PLX-4720
Experimental
(S)-famoxadone
Experimental
Nifekalant
Nifekalant is under investigation in clinical trial NCT03855826 (Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection).
Investigational
Magnesium phosphate
Experimental
Nevanimibe
Nevanimibe is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome).
Investigational
N-Methylmesoporphyrin containing copper
Experimental
(S)-methoprene
Vet approved
Meglumine antimoniate
Experimental
Investigational
Olafertinib
Investigational
Cannabidiolic acid methyl ester
Investigational
Cobamamide
Cobamamide is one of the active forms of vitamin B12 that is also known as adenosylcobalamin or dibencozide. This drug is available as a nutritional supplement to prevent vitamin B12 deficiency.
Vitamin B12 is a collective term for these variously substituted corrinoids. The principal biochemical participants are two coenzyme forms...
Nutraceutical
Temelimab
Temelimab is under investigation in clinical trial NCT02782858 (Clinical Trial Assessing the HERV-W Env Antagonist Gnbac1 for Efficacy in MS).
Investigational
Rintatolimod
Experimental
Zamerovimab
Investigational
Golidocitinib
Investigational
Displaying drugs 4651 - 4675 of 5559 in total